Hygeia Healthcare Holdings Co., Limited (06078.HK)

Hygeia Healthcare Holdings Co., Ltd. operates as a biopharmaceutical company that focuses on the development of new clinical drugs. The company is headquartered in Shanghai, Shanghai and currently employs 8,017 full-time employees. The company went IPO on 2020-06-29. The firm operates its businesses through two business segments. The Hospital Business segment provides one-stop comprehensive oncology diagnosis and treatment services, and carries out multi-disciplinary medical services centered around the core oncology business, including providing various oncology healthcare services including radiotherapy, chemotherapy, surgery, and targeted therapy, and gradually cover cancer diagnosis, treatment, and rehabilitation. The Other Business segment is mainly engaged in other businesses. The firm mainly conducts its businesses within domestic market.